vs

Side-by-side financial comparison of Ballard Power Systems Inc. (BLDP) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.

Pulmonx Corp is the larger business by last-quarter revenue ($20.6M vs $17.7M, roughly 1.2× Ballard Power Systems Inc.). Ballard Power Systems Inc. runs the higher net margin — 994.4% vs -66.3%, a 1060.8% gap on every dollar of revenue.

Ballard Power Systems Inc. is a developer and manufacturer of proton exchange membrane (PEM) fuel cell products for markets such as heavy-duty motive, portable power, material handling as well as engineering services. Ballard has designed and shipped over 400 MW of fuel cell products to date.

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

BLDP vs LUNG — Head-to-Head

Bigger by revenue
LUNG
LUNG
1.2× larger
LUNG
$20.6M
$17.7M
BLDP
Higher net margin
BLDP
BLDP
1060.8% more per $
BLDP
994.4%
-66.3%
LUNG

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BLDP
BLDP
LUNG
LUNG
Revenue
$17.7M
$20.6M
Net Profit
$176.5M
$-13.7M
Gross Margin
77.9%
Operating Margin
-40.9%
Net Margin
994.4%
-66.3%
Revenue YoY
-8.7%
Net Profit YoY
5.5%
EPS (diluted)
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLDP
BLDP
LUNG
LUNG
Q1 26
$20.6M
Q4 25
$22.6M
Q3 25
$17.7M
$21.5M
Q2 25
$23.9M
Q1 25
$22.5M
Q4 24
$23.8M
Q3 24
$-12.3M
$20.4M
Q2 24
$20.8M
Net Profit
BLDP
BLDP
LUNG
LUNG
Q1 26
$-13.7M
Q4 25
$-10.4M
Q3 25
$176.5M
$-14.0M
Q2 25
$-15.2M
Q1 25
$-14.4M
Q4 24
$-13.2M
Q3 24
$-14.1M
Q2 24
$-15.3M
Gross Margin
BLDP
BLDP
LUNG
LUNG
Q1 26
77.9%
Q4 25
77.6%
Q3 25
74.7%
Q2 25
72.1%
Q1 25
72.5%
Q4 24
74.0%
Q3 24
156.5%
73.7%
Q2 24
73.7%
Operating Margin
BLDP
BLDP
LUNG
LUNG
Q1 26
-40.9%
Q4 25
-43.8%
Q3 25
-66.9%
Q2 25
-62.0%
Q1 25
-64.6%
Q4 24
-56.5%
Q3 24
-69.3%
Q2 24
-75.2%
Net Margin
BLDP
BLDP
LUNG
LUNG
Q1 26
-66.3%
Q4 25
-46.1%
Q3 25
994.4%
-64.9%
Q2 25
-63.6%
Q1 25
-64.1%
Q4 24
-55.4%
Q3 24
-69.4%
Q2 24
-73.7%
EPS (diluted)
BLDP
BLDP
LUNG
LUNG
Q1 26
$-0.33
Q4 25
$-0.25
Q3 25
$-0.34
Q2 25
$-0.38
Q1 25
$-0.36
Q4 24
$-0.33
Q3 24
$-0.36
Q2 24
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLDP
BLDP
LUNG
LUNG
Cash + ST InvestmentsLiquidity on hand
$61.6M
Total DebtLower is stronger
$37.3M
Stockholders' EquityBook value
$45.8M
Total Assets
$120.0M
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLDP
BLDP
LUNG
LUNG
Q1 26
$61.6M
Q4 25
$69.8M
Q3 25
$76.5M
Q2 25
$75.5M
Q1 25
$74.6M
Q4 24
$70.9M
Q3 24
$63.3M
Q2 24
$63.5M
Total Debt
BLDP
BLDP
LUNG
LUNG
Q1 26
$37.3M
Q4 25
$37.1M
Q3 25
$37.1M
Q2 25
$37.1M
Q1 25
$37.2M
Q4 24
$37.2M
Q3 24
$37.2M
Q2 24
$37.2M
Stockholders' Equity
BLDP
BLDP
LUNG
LUNG
Q1 26
$45.8M
Q4 25
$54.1M
Q3 25
$60.0M
Q2 25
$69.1M
Q1 25
$77.7M
Q4 24
$85.8M
Q3 24
$93.9M
Q2 24
$101.2M
Total Assets
BLDP
BLDP
LUNG
LUNG
Q1 26
$120.0M
Q4 25
$129.3M
Q3 25
$138.3M
Q2 25
$147.2M
Q1 25
$150.7M
Q4 24
$162.8M
Q3 24
$167.4M
Q2 24
$172.6M
Debt / Equity
BLDP
BLDP
LUNG
LUNG
Q1 26
0.82×
Q4 25
0.69×
Q3 25
0.62×
Q2 25
0.54×
Q1 25
0.48×
Q4 24
0.43×
Q3 24
0.40×
Q2 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLDP
BLDP
LUNG
LUNG
Operating Cash FlowLast quarter
$5.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.03×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLDP
BLDP
LUNG
LUNG
Q1 26
Q4 25
$-7.1M
Q3 25
$5.7M
$-8.2M
Q2 25
$-3.9M
Q1 25
$-13.2M
Q4 24
$-6.7M
Q3 24
$-6.6M
$-7.2M
Q2 24
$-5.8M
Free Cash Flow
BLDP
BLDP
LUNG
LUNG
Q1 26
Q4 25
$-7.1M
Q3 25
$-8.3M
Q2 25
$-4.0M
Q1 25
$-13.5M
Q4 24
$-6.8M
Q3 24
$-7.7M
Q2 24
$-6.2M
FCF Margin
BLDP
BLDP
LUNG
LUNG
Q1 26
Q4 25
-31.4%
Q3 25
-38.4%
Q2 25
-16.6%
Q1 25
-60.0%
Q4 24
-28.8%
Q3 24
-37.6%
Q2 24
-30.0%
Capex Intensity
BLDP
BLDP
LUNG
LUNG
Q1 26
Q4 25
0.1%
Q3 25
0.4%
Q2 25
0.2%
Q1 25
1.3%
Q4 24
0.5%
Q3 24
2.0%
Q2 24
2.3%
Cash Conversion
BLDP
BLDP
LUNG
LUNG
Q1 26
Q4 25
Q3 25
0.03×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons